Norway
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 237.29 M
|
Dec. 31, 2023 | USD 17.56 | 0.15% |
|
Norway |
|
2 |
USD 14.33 M
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
3 |
USD 11.06 M
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
4 |
USD 9.53 M
|
Dec. 31, 2023 | USD 0.27 | 1.85% |
|
Norway |
|
5 |
USD 1.33 M
|
Dec. 31, 2023 | USD 0.19 | -0.80% |
|
Norway |
|
6 |
USD 913.21 K
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
7 |
USD 891.33 K
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
8 |
USD 826.14 K
|
Dec. 31, 2023 | USD 1.26 | -2.20% |
|
Norway |
The Biotechnology company in Norway with the highest Total Non-Current Liabilities is Borregaard ASA (Oslo Stock Exchange: BRG.OL) at USD 237.29 M.
The Biotechnology company in Norway with the lowest Total Non-Current Liabilities is ArcticZymes Technologies ASA (Oslo Stock Exchange: AZT.OL) at USD 826.14 K.
The top 10 Biotechnology companies in Norway by Total Non-Current Liabilities are Borregaard ASA, Photocure ASA, Navamedic ASA, Hofseth BioCare ASA, Ultimovacs ASA, Lifecare AS, Gentian Diagnostics ASA and ArcticZymes Technologies ASA.
The bottom 10 Biotechnology companies in Norway by Total Non-Current Liabilities are ArcticZymes Technologies ASA, Gentian Diagnostics ASA, Lifecare AS, Ultimovacs ASA, Hofseth BioCare ASA, Navamedic ASA, Photocure ASA and Borregaard ASA.